Newsfeeds - Spark Newswire

1 minute read

Military University Hospital Prague Selects ViewRay’s MRIdian MRI-Guided Radiation Therapy System to Treat Cancer

Today, 5:44 AM

This is the first and only hospital to offer the precision of MRIdian Stereotactic MRI-guided Adaptive Radiotherapy (SMART) in the Czech Republic. The purchase was co-financed by the REACT-EU financial

VRAY

1 minute read

ViewRay Q4 EPS $(0.15) Beats $(0.16) Estimate, Sales $34.69M Beat $33.89M Estimate

By Benzinga Newsdesk

Today, 5:44 AM

ViewRay (NASDAQ:VRAY) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.16) by 6.25 percent. This is a 6.25 percent increase over losses of $(0.16) per share from the same

VRAY

1 minute read

ViewRay Announced Findings Published in JAMA Oncology Demonstrate Superiority of MRIdian® MRI-Guidance in Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer

By Charles Gross

Today, 5:44 AM

ViewRay, Inc. (NASDAQ: VRAY) today announced that findings from the phase III randomized controlled MIRAGE trial (NCT04384770) were published on January 12 in JAMA Oncology.

VRAY

2 minute read

University Hospitals In Cleveland Enters Into Master Purchase Agreement With ViewRay For Multiple MRIdian Systems

By Benzinga Newsdesk

Today, 5:44 AM

ViewRay, Inc. (NASDAQ:VRAY) today announced that the University Hospitals (UH) Seidman Cancer Center in Cleveland has selected a MRIdian MR-Guided Radiation Therapy System as part of a master agreement for the purchase

VRAY

1 minute read

Earnings

ViewRay’s Earnings: A Preview

By Benzinga Insights

Today, 5:44 AM

ViewRay (NASDAQ:VRAY) is set to give its latest quarterly earnings report on Tuesday, 2022-11-01. Here's what investors need to know before the announcement. Analysts estimate that ViewRay will report an earnings per share (EPS) of $-0.14.

VRAY